Gadodiamide Injectable Solution 0.5 mol/L Suppliers & Bulk Manufacturers
Available Forms: Injectable Solution
Available Strengths: 0.5 mol/L
Reference Brands: Omniscan(US & EU)
Category: Contrast Agent
Gadodiamide is a gadolinium-based contrast agent that enhances MRI scans by increasing tissue radiopacity. It improves visualization of blood vessels, organs, and abnormalities, supporting accurate diagnosis. Benefits include high image quality, rapid excretion, safety, and detailed imaging support in neurological, cardiovascular, and musculoskeletal diagnostics worldwide.
Product Description:
Gadodiamide, marketed as Omniscan, is approved in the US by the FDA and in the EU via EMA for MRI contrast enhancement of neurological, cardiovascular, and musculoskeletal imaging. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports swift approval, safe use, and global availability, facilitating high-quality diagnostic imaging worldwide.
Gadodiamide Injectable Solution — third party manufacturing & bulk supply
Gadodiamide Injectable Solution 0.5 mol/L is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Gadodiamide Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Gadodiamide Injectable Solution →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Gadodiamide is used as a contrast agent in magnetic resonance imaging (MRI) to enhance the visibility of internal body structures. It is commonly used for imaging the brain, spine, and other tissues to help diagnose abnormalities such as tumors, infections, and vascular conditions.
Gadodiamide is a gadolinium-based compound in which gadolinium, a paramagnetic metal, is bound to a chelating agent to improve safety and allow its use as an MRI contrast medium.
The primary trade name of gadodiamide is Omniscan.
Gadodiamide (Omniscan) was originally developed and marketed by GE Healthcare and is also produced by other manufacturers in generic forms.
The generic name is gadodiamide.
The main brand name is Omniscan.
Gadodiamide is manufactured in multiple countries including the USA, Ireland, India, and other regions with facilities for producing contrast media.
Related Products
Gadobenate Dimeglumine
Strength:
529 mg/mL
Form: Injection
Reference Brands: MultiHance (USA)
View Details
Gadopiclenol
Strength:
0.25 mmol/mL
Form: Injection
Reference Brands: Elucirem (USA), Vueway(EU)
View Details
Perflutren
Strength:
0.19 mg/ ml
Form: Injection
Reference Brands: Definity (USA), Optison (USA), Luminity (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
